Briacell Therapeutics CORP 8-K filings
NASDAQ
8-K: BriaCell Therapeutics Corp. Holds Annual General Meeting, Elects Directors and Ratifies Auditors
BriaCell Therapeutics Corp. held its Annual General Meeting on January 30, 2024, where shareholders elected seven directors and ratified the appointment of MNP LLP as auditors.